Healthpeak Properties (NYSE:DOC) Releases FY 2025 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 1.810-1.870 for the period, compared to the consensus EPS estimate of 1.860. The company issued revenue guidance of -.

Healthpeak Properties Trading Down 1.2 %

Shares of Healthpeak Properties stock opened at $20.41 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties has a twelve month low of $16.01 and a twelve month high of $23.26. The firm has a market capitalization of $14.27 billion, a PE ratio of 43.42, a P/E/G ratio of 2.22 and a beta of 1.15. The firm’s 50-day moving average price is $20.75 and its 200 day moving average price is $21.55.

Healthpeak Properties Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th will be given a dividend of $0.305 per share. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 5.98%. Healthpeak Properties’s payout ratio is presently 255.32%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on DOC. Robert W. Baird upped their price target on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research note on Wednesday, January 15th. Royal Bank of Canada boosted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Finally, Mizuho dropped their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.